New

Remicade Drug Market

2021

Remicade Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type ( Branded Drugs, Generic Drugs ); Application ( Crohn's Disease, Pediatric Crohn's Disease, Ulcerative Colitis, Pediatric Ulcerative Colitis, Other )

| Report Code: TIPRE00019325 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Remicade Drug Market 2028 By Product Type, Application | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Infliximab a monoclonal antibody is marketed as Remicade and is used to treat autoimmune diseases. It is used to treat conditions like ulcerative colitis, Crohn's disease, psoriasis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Behçet's disease. It binds to TNF-? thereby preventing autoimmune reaction.

MARKET DYNAMICS

The remicade drug market is driving due to the increasing research on treating autoimmune diseases and growing cases of many autoimmune diseases. Moreover, growing awareness for autoimmune diseases in developed as well as developing countries is likely to create growth opportunities in the market.

MARKET SCOPE

The "Remicade drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Remicade drug market with detailed market segmentation by product type and application. The remicade drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Remicade drug market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The remicade drug market is segmented on the basis of product type, and application. Based on product type the market is segmented as branded drugs and generic drugs. The application segment is divided into crohn's disease, pediatric crohn's disease, ulcerative colitis, pediatric ulcerative colitis, and other.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the remicade drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The remicade drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting remicade drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the remicade drug market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the remicade drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from remicade drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for remicade drug in the global market. Below mentioned is the list of few companies engaged in the remicade drug market.

The report also includes the profiles of key players in remicade drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Merck And Co
  •   Celltrion Inc.
  •   NAPP Pharmaceuticals
  •   Janssen Biotech Inc
  •   PFIZER Inc
  •   Alvogen
  •   Nippon Kayaku
  •   Amgen Inc.
  •   Ranbaxy Laboratories
  •   Samsung Bioepis

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Remicade Drug Market - By Product Type
1.3.2 Remicade Drug Market - By Application
1.3.3 Remicade Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. REMICADE DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. REMICADE DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. REMICADE DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. REMICADE DRUG - GLOBAL MARKET OVERVIEW
6.2. REMICADE DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. REMICADE DRUG MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. BRANDED DRUGS
7.3.1. Overview
7.3.2. Branded Drugs Market Forecast and Analysis
7.4. GENERIC DRUGS
7.4.1. Overview
7.4.2. Generic Drugs Market Forecast and Analysis
8. REMICADE DRUG MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CROHN'S DISEASE
8.3.1. Overview
8.3.2. Crohn's Disease Market Forecast and Analysis
8.4. PEDIATRIC CROHN'S DISEASE
8.4.1. Overview
8.4.2. Pediatric Crohn's Disease Market Forecast and Analysis
8.5. ULCERATIVE COLITIS
8.5.1. Overview
8.5.2. Ulcerative Colitis Market Forecast and Analysis
8.6. PEDIATRIC ULCERATIVE COLITIS
8.6.1. Overview
8.6.2. Pediatric Ulcerative Colitis Market Forecast and Analysis
8.7. OTHER
8.7.1. Overview
8.7.2. Other Market Forecast and Analysis
9. REMICADE DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Remicade Drug Market Overview
9.1.2 North America Remicade Drug Market Forecasts and Analysis
9.1.3 North America Remicade Drug Market Forecasts and Analysis - By Product Type
9.1.4 North America Remicade Drug Market Forecasts and Analysis - By Application
9.1.5 North America Remicade Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Remicade Drug Market
9.1.5.1.1 United States Remicade Drug Market by Product Type
9.1.5.1.2 United States Remicade Drug Market by Application
9.1.5.2 Canada Remicade Drug Market
9.1.5.2.1 Canada Remicade Drug Market by Product Type
9.1.5.2.2 Canada Remicade Drug Market by Application
9.1.5.3 Mexico Remicade Drug Market
9.1.5.3.1 Mexico Remicade Drug Market by Product Type
9.1.5.3.2 Mexico Remicade Drug Market by Application
9.2. EUROPE
9.2.1 Europe Remicade Drug Market Overview
9.2.2 Europe Remicade Drug Market Forecasts and Analysis
9.2.3 Europe Remicade Drug Market Forecasts and Analysis - By Product Type
9.2.4 Europe Remicade Drug Market Forecasts and Analysis - By Application
9.2.5 Europe Remicade Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Remicade Drug Market
9.2.5.1.1 Germany Remicade Drug Market by Product Type
9.2.5.1.2 Germany Remicade Drug Market by Application
9.2.5.2 France Remicade Drug Market
9.2.5.2.1 France Remicade Drug Market by Product Type
9.2.5.2.2 France Remicade Drug Market by Application
9.2.5.3 Italy Remicade Drug Market
9.2.5.3.1 Italy Remicade Drug Market by Product Type
9.2.5.3.2 Italy Remicade Drug Market by Application
9.2.5.4 Spain Remicade Drug Market
9.2.5.4.1 Spain Remicade Drug Market by Product Type
9.2.5.4.2 Spain Remicade Drug Market by Application
9.2.5.5 United Kingdom Remicade Drug Market
9.2.5.5.1 United Kingdom Remicade Drug Market by Product Type
9.2.5.5.2 United Kingdom Remicade Drug Market by Application
9.2.5.6 Rest of Europe Remicade Drug Market
9.2.5.6.1 Rest of Europe Remicade Drug Market by Product Type
9.2.5.6.2 Rest of Europe Remicade Drug Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Remicade Drug Market Overview
9.3.2 Asia-Pacific Remicade Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Remicade Drug Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Remicade Drug Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Remicade Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Remicade Drug Market
9.3.5.1.1 Australia Remicade Drug Market by Product Type
9.3.5.1.2 Australia Remicade Drug Market by Application
9.3.5.2 China Remicade Drug Market
9.3.5.2.1 China Remicade Drug Market by Product Type
9.3.5.2.2 China Remicade Drug Market by Application
9.3.5.3 India Remicade Drug Market
9.3.5.3.1 India Remicade Drug Market by Product Type
9.3.5.3.2 India Remicade Drug Market by Application
9.3.5.4 Japan Remicade Drug Market
9.3.5.4.1 Japan Remicade Drug Market by Product Type
9.3.5.4.2 Japan Remicade Drug Market by Application
9.3.5.5 South Korea Remicade Drug Market
9.3.5.5.1 South Korea Remicade Drug Market by Product Type
9.3.5.5.2 South Korea Remicade Drug Market by Application
9.3.5.6 Rest of Asia-Pacific Remicade Drug Market
9.3.5.6.1 Rest of Asia-Pacific Remicade Drug Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Remicade Drug Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Remicade Drug Market Overview
9.4.2 Middle East and Africa Remicade Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Remicade Drug Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Remicade Drug Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Remicade Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Remicade Drug Market
9.4.5.1.1 South Africa Remicade Drug Market by Product Type
9.4.5.1.2 South Africa Remicade Drug Market by Application
9.4.5.2 Saudi Arabia Remicade Drug Market
9.4.5.2.1 Saudi Arabia Remicade Drug Market by Product Type
9.4.5.2.2 Saudi Arabia Remicade Drug Market by Application
9.4.5.3 U.A.E Remicade Drug Market
9.4.5.3.1 U.A.E Remicade Drug Market by Product Type
9.4.5.3.2 U.A.E Remicade Drug Market by Application
9.4.5.4 Rest of Middle East and Africa Remicade Drug Market
9.4.5.4.1 Rest of Middle East and Africa Remicade Drug Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Remicade Drug Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Remicade Drug Market Overview
9.5.2 South and Central America Remicade Drug Market Forecasts and Analysis
9.5.3 South and Central America Remicade Drug Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Remicade Drug Market Forecasts and Analysis - By Application
9.5.5 South and Central America Remicade Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Remicade Drug Market
9.5.5.1.1 Brazil Remicade Drug Market by Product Type
9.5.5.1.2 Brazil Remicade Drug Market by Application
9.5.5.2 Argentina Remicade Drug Market
9.5.5.2.1 Argentina Remicade Drug Market by Product Type
9.5.5.2.2 Argentina Remicade Drug Market by Application
9.5.5.3 Rest of South and Central America Remicade Drug Market
9.5.5.3.1 Rest of South and Central America Remicade Drug Market by Product Type
9.5.5.3.2 Rest of South and Central America Remicade Drug Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL REMICADE DRUG MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. REMICADE DRUG MARKET, KEY COMPANY PROFILES
12.1. MERCK AND CO
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CELLTRION INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NAPP PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JANSSEN BIOTECH INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ALVOGEN
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NIPPON KAYAKU
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AMGEN INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. RANBAXY LABORATORIES
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SAMSUNG BIOEPIS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Merck And Co
2. Celltrion Inc.
3. NAPP Pharmaceuticals
4. Janssen Biotech Inc
5. PFIZER Inc
6. Alvogen
7. Nippon Kayaku
8. Amgen Inc.
9. Ranbaxy Laboratories
10. Samsung Bioepis
TIPRE00019325
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.